MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults [PDF]
Respiratory tract infections (RTIs) are among the most common and important problems in clinical medicine, making antibiotics the gold standard therapeutic option regardless of their frequent viral etiology.
Karla Montalbán-Hernández +6 more
doaj +5 more sources
Role of multi-strain probiotics in preventing severity and frequency of recurrent respiratory tract infections in children [PDF]
Background Respiratory tract infections are among the most common infections in the pediatric population throughout the globe. Globally around 20% of all deaths in children below 5 years of age are secondary to acute respiratory infections, mostly ...
Imran Khan Laghari +4 more
doaj +3 more sources
OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis [PDF]
Background Despite the growing evidence on efficacy, little is known regarding the cost-utility of Vaxom/Imocur (OM-85 BV) supplementation to decrease the probability of recurrent respiratory tract infections in OM-85 BV to reduce the incidence of ...
Jefferson Antonio Buendía +2 more
doaj +3 more sources
Mycoplasma pneumoniae carriage in children with recurrent respiratory tract infections is associated with a less diverse and altered microbiota [PDF]
Summary Background Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in school-aged children and can be preceded by asymptomatic carriage. However, its role in recurrent respiratory tract infections is unclear.
Jeroen D Langereis +2 more
exaly +3 more sources
A woman with recurrent respiratory tract infections [PDF]
A 76-year-old Caucasian woman who has been repeatedly hospitalized with recurrent respiratory tract infections, presented to the emergency department with fever and productive cough during the last 24 hours.
Petros Ioannou
doaj +5 more sources
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis [PDF]
Introduction Despite the growing evidence on efficacy, few economic evaluations have evaluated the cost-utility of Pidotimod (PDT) supplementation to decrease the probability of recurrent respiratory tract infections in children.
Jefferson Antonio Buendía +2 more
doaj +3 more sources
Advancements related to probiotics for preventing and treating recurrent respiratory tract infections in children [PDF]
Recurrent respiratory tract infections (RRTIs) are a common condition in pediatrics and significantly impact children's quality of life; however, their pathogenesis and contributing factors are not yet fully elucidated.
Yingying Xu, Yali Zhang, Xiaomei Wang
exaly +3 more sources
Oropharyngeal Probiotic ENT-K12 as an Effective Dietary Intervention for Children With Recurrent Respiratory Tract Infections During Cold Season [PDF]
Recurrent respiratory tract infections (RRTi) cause a high burden of disease and lead to negative impact on quality of life, frequent school/work absenteeism, and doctor visits, which remain a great challenge to pediatricians because RRTi can increase ...
Si Qin
exaly +3 more sources
Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study [PDF]
Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors.
Zuzana Rennerova +13 more
doaj +3 more sources
Background: The implications of gastroesophageal reflux disease in respiratory tract infections have been investigated over time. The aim of our study was to evaluate the relationship between these two pathologic entities and the outcome after proper ...
Vasile Valeriu Lupu +12 more
doaj +4 more sources

